Prof. Dr. Philippe Pereira

It was a sensation for our clinical colleagues to discover the report made with mint Lesion™, which is able to present all the clinical and radiological data together, making it possible to evaluate patient follow-ups more quickly.

Related Resources

Related Resources

A diagram and a CT scan visualizing tumor growth rate in patients with refractory or relapsed lymphoma

Study with mint Lesion™ Uncovers the Impact of Tumor Growth Rate in Predicting the Efficacy of CAR-T-cell Therapy in Lymphoma Patients

A recent study conducted by Dr. med. Michael Winkelmann and his colleagues at the LMU Klinikum München explored the association between TGR dynamics…

ESOI-EORTC Hands-On Workshop 2023

11/02 to 11/04/2023 MUNICH, GERMANY

Imaging in assessing response to cancer therapy – a hands-on course

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…